Yuan Sun
Directeur/Membre du Conseil chez LAEKNA, INC.
Profil
Yuan Sun is currently a Director at CS Capital Ltd., a Director at Laekna Therapeutics (Shanghai) Co., Ltd., and a Non-Executive Director at Laekna, Inc. Previously, Mr. Sun served as a Non-Executive Director at Adlai Nortye Ltd.
Mr. Sun holds a graduate degree from the University of Washington and an undergraduate degree from Tsinghua University.
Postes actifs de Yuan Sun
| Sociétés | Poste | Début |
|---|---|---|
| LAEKNA, INC. | Directeur/Membre du Conseil | 28/04/2022 |
CS Capital Ltd.
 CS Capital Ltd. Investment ManagersFinance CS Capital Ltd. provides investment advisory services. The private company is based in Bangkok, Thailand. | Directeur/Membre du Conseil | 01/01/2022 |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | - |
Anciens postes connus de Yuan Sun
| Sociétés | Poste | Fin |
|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Membre du Conseil | - |
Formation de Yuan Sun
| University of Washington | Graduate Degree |
| Tsinghua University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| LAEKNA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
CS Capital Ltd.
CS Capital Ltd. Investment ManagersFinance CS Capital Ltd. provides investment advisory services. The private company is based in Bangkok, Thailand. | Finance |
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
